- Home
- BDTX vs PLBY Comparison
BDTX vs PLBY Comparison
Compare BDTX & PLBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- PLBY
- Stock Information
- Founded
- BDTX 2014
- PLBY 1953
- Country
- BDTX United States
- PLBY United States
- Employees
- BDTX N/A
- PLBY 615
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- PLBY Recreational Games/Products/Toys
- Sector
- BDTX Health Care
- PLBY Consumer Discretionary
- Exchange
- BDTX Nasdaq
- PLBY Nasdaq
- Market Cap
- BDTX 181.4M
- PLBY 187.1M
- IPO Year
- BDTX 2020
- PLBY N/A
- Fundamental
- Price
- BDTX $2.94
- PLBY $1.74
- Analyst Decision
- BDTX Strong Buy
- PLBY Strong Buy
- Analyst Count
- BDTX 6
- PLBY 1
- Target Price
- BDTX $12.50
- PLBY $3.00
- AVG Volume (30 Days)
- BDTX 802.5K
- PLBY 251.6K
- Earning Date
- BDTX 11-04-2025
- PLBY 08-12-2025
- Dividend Yield
- BDTX N/A
- PLBY N/A
- EPS Growth
- BDTX N/A
- PLBY N/A
- EPS
- BDTX 0.25
- PLBY N/A
- Revenue
- BDTX $70,000,000.00
- PLBY $119,954,000.00
- Revenue This Year
- BDTX N/A
- PLBY $6.32
- Revenue Next Year
- BDTX N/A
- PLBY $3.49
- P/E Ratio
- BDTX $11.74
- PLBY N/A
- Revenue Growth
- BDTX N/A
- PLBY N/A
- 52 Week Low
- BDTX $1.20
- PLBY $0.54
- 52 Week High
- BDTX $6.33
- PLBY $2.44
- Technical
- Relative Strength Index (RSI)
- BDTX 57.58
- PLBY 54.21
- Support Level
- BDTX $2.56
- PLBY $1.62
- Resistance Level
- BDTX $2.95
- PLBY $1.73
- Average True Range (ATR)
- BDTX 0.16
- PLBY 0.07
- MACD
- BDTX 0.02
- PLBY 0.00
- Stochastic Oscillator
- BDTX 79.00
- PLBY 87.50
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About PLBY PLBY Group Inc.
Playboy Inc, formerly PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.